# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010270
Filing Date
2025-05-14
Accepted
2025-05-14 16:10:50
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1109348
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 18544
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 18463
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 8955
5 | EX-32.2 | ex32-2.htm | EX-32.2 | 9131
| Complete submission text file | 0001641172-25-010270.txt |  | 5907399

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | cycc-20250331.xsd | EX-101.SCH | 42889
7 | XBRL CALCULATION FILE | cycc-20250331_cal.xml | EX-101.CAL | 45162
8 | XBRL DEFINITION FILE | cycc-20250331_def.xml | EX-101.DEF | 234963
9 | XBRL LABEL FILE | cycc-20250331_lab.xml | EX-101.LAB | 400378
10 | XBRL PRESENTATION FILE | cycc-20250331_pre.xml | EX-101.PRE | 312486
65 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 871331

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 25945576
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)